|Chemical and physical data|
|Molar mass||377.5 g/mol|
|3D model (Jmol)||Interactive image|
CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.
- "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015.
- Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
- "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
- "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.